Secondary Logo

Journal Logo

October 2004 - Volume 32 - Issue 10
pp: 1989-2172


Recombinant urokinase is safe and effective in restoring patency to occluded central venous access devices: A multiple-center, international trial*?

Svoboda, Petr; Barton, R Philip; Barbarash, Olga L.; More

Critical Care Medicine. 32(10):1990-1996, October 2004.



The effect of anti-L-selectin (aselizumab) in multiple traumatized patients—Results of a phase II clinical trial*

Seekamp, Andreas; van Griensven, Martijn; Dhondt, Erwin; More

Critical Care Medicine. 32(10):2021-2028, October 2004.











Show: